Metabolism of zaleplon by human liver: Evidence for involvement of aldehyde oxidase

Xenobiotica

Volumn 32, Issue 10, 2002, Pages 835-847

  Lake, B G ^a   Ball, S E ^a   Kao, J ^a   Renwick, A B ^a   Price, R J ^a   Scatina, J A ^a  

^a TNO BIBRA International Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE OXIDASE; CHLORPROMAZINE; CIMETIDINE; CYTOCHROME P450 3A; ENZYME INHIBITOR; HYDRALAZINE; MENADIONE; PHENANTHRIDINE DERIVATIVE; PHTHALAZINE DERIVATIVE; PROMETHAZINE; ZALEPLON;

ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; HUMAN; HUMAN CELL; HUMAN TISSUE; KINETICS; LIVER CYTOSOL; LIVER METABOLISM; LIVER SLICE;

ACETAMIDES; ALDEHYDE OXIDASE; ALDEHYDE OXIDOREDUCTASES; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 CYP3A; CYTOSOL; HUMANS; HYPNOTICS AND SEDATIVES; KINETICS; LIVER; MODELS, CHEMICAL; OXIDOREDUCTASES, N-DEMETHYLATING; PHTHALAZINES; PYRIMIDINES; WATER;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0036795513     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/00498250210158915     Document Type: Article

References (26)

1. Acheampong, A. A., Chien, D.-S., Lam, S., Vekich, S., Breau, A., Usansky, J., Harcourt, D., Munk, S. A., Nguyen, H., Garst, M. and Tang-Liu, D., 1996, Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase. Xenobiotica, 26, 1035-1055.
2. Beamand, J. A., Price, R. J., Cunninghame, M. E. and Lake, B. G., 1993, Culture of precision-cut liver slices: effect of some peroxisome proliferators. Food and Chemical Toxicology, 31, 137-147.
3. Beedham, C., 1987, Molybdenum hydroxylases: biological distribution and substrate-inhibitor specificity. In G. P. Ellis and G. B. West (eds), Progress in Medicinal Chemistry, vol. 24 (Amsterdam: Elsevier), pp. 85-127.
4. Beedham, C., Bruce, S. E., Critchley, D. J., Al-Tayib, Y. and Rance, D. J., 1987, Species variation in hepatic aldehyde oxidase activity. European Journal of Drug Metabolism and Pharmacokinetics, 12, 307-310.
5. Beer, B., Ieni, J. R., Wu, W.-H., Clody, D., Amorusi, P., Rose, J., Mant, T., Gaudreault, J., Cato, A. and Stern, W., 1994, A placebo-controlled evaluation of single, escalating doses of CL-284,846, a non-benzodiazepine hypnotic. Journal of Clinical Pharmacology, 34, 335-344.
6. Chaudhary, I., Demalo, W. and Kantrowitz, J., 1994, Species comparison of in vitro and in vivo metabolism of CL-284,846, a non-benzodiazepine sedative/hypnotic agent. Pharmaceutical Research, 11, S391.
7. Dixon, M., 1953, The determination of enzyme inhibitor constants. Biochemical Journal, 55, 170-171.
8. Johns, D. G., 1967, Human liver aldehyde oxidase: differential inhibition of oxidation of charged and uncharged substrates. Journal of Clinical Investigation, 46, 1492-1505.
9. Johnson, C., Stubley-Beedham, C. and Stell, J. G. P., 1984, Elevation of molybdenum hydroxylase levels in rabbit liver after ingestion of phthalazine or its hydroxylated metabolite. Biochemical Pharmacology, 33, 3699-3705.
10. Johnson, C., Stubbley-Beedham, C. and Stell, J. G. P., 1985, Hydralazine: a potent inhibitor of aldehyde oxidase activity in vitro and in vivo. Biochemical Pharmacology, 34, 4251-4256.
11. Kawashima, K., Hosoi, K., Naruke, T., Shiba, T., Kitamura, M. and Watabe, T., 1999, Aldehyde oxidase-dependent marked species difference in hepatic metabolism of the sedative-hypnotic, zaleplon, between monkeys and rats. Drug Metabolism and Disposition, 27, 422-428.
12. Lake, B. G., Ball, S. E., Renwick, A. B., Tredger, J. M., Kao, J., Beamand, J. A. and Price, R. J., 1997, Induction of CYP3A isoforms in cultured precision-cut human liver slices. Xenobiotica, 27, 1165-1173.
13. Lake, B. G., Tredger, J. M., Renwick, A. B., Barton, P. B. and Price, R. J., 1998, 3,3′-Diindolylmethane induces CYP1A2 in cultured precision-cut human liver slices. Xenobiotica, 28, 803-811.
14. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J., 1951, Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
15. Rajagopalan, K. V. and Handler, P., 1966, Aldehyde oxidase. Methods in Enzymology, 9, 364-368.
16. Rashidi, M. R., Smith, J. A., Clarke, S. E. and Beedham, C., 1995, Inhibition of human and guinea-pig liver aldehyde oxidases in-vitro. Journal of Pharmacy and Pharmacology, 47, 1090.
17. Rashidi, M. R., Smith, J. A., Clarke, S. E. and Beedham, C., 1997, In vitro oxidation of famciclovir and 6-deoxypenciclovir by aldehyde oxidase from human, guinea pig, rabbit, and rat liver. Drug Metabolism and Disposition, 25, 805-813.
18. Renwick, A. B., Mistry, H., Ball, S. E., Walters, D. G., Kao, J. and Lake, B. G., 1998, Metabolism of zaleplon by human hepatic microsomal cytochrome P450 isoforms. Xenobiotica, 28, 337-348.
19. Rodrigues, A. D., 1994, Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro. Biochemical Pharmacology, 48, 197-200.
20. Rodrigues, A. D., Ferrero, J. L., Amann, M. T., Rotert, G. A., Cepa, S. P., Surber, B. W., Machinist, J. M., Tich, N. R., Sullivan, J. P., Garvey, D. S., Fitzgerald, M. and Arneric, S. P., 1994, The in vitro hepatic metabolism of ABT-418, a cholinergic channel activator, in rats, dogs, Cynomolgus monkeys, and humans. Drug Metabolism and Disposition, 22, 788-798.
21. Rosen, A. S., Fournie, P., Darwish, M., Danjou, P. and Troy, S. M., 1999, Zaleplon pharmacokinetics and absolute bioavailability. Biopharmaceutics and Drug Disposition, 20, 171-175.
22. Somogyi, A. and Muirhead, M., 1987, Pharmacokinetic interactions of cimetidine 1987. Clinical Pharmacokinetics, 12, 321-366.
23. Steensma, A., Beamand, J. A., Walters, D. G., Price, R. J. and Lake, B. G., 1994, Metabolism of coumarin and 7-ethoxycoumarin by rat, guinea pig, Cynomolgus monkey and human precision-cut liver slices. Xenobiotica, 24, 893-907.
24. Tanaka, E., 1998, Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes. Journal of Clinical Pharmacy and Therapeutics, 23, 403-416.
25. Wu, W. H., Dicioccio, A. T., Demaio, W., Amorusi, P., Tonelli, A. P. and Mayer, P. R., 1996, Mass balance and pharmacokinetics of zaleplon, a non-benzodiazepine sedative/hypnotic, in man. Pharmaceutical Research, 13, S487.
26. Yoshihara, S. and Tatsumi, K., 1986, Kinetic and inhibition studies on reduction of diphenyl sulphoxide by guinea pig liver aldehyde oxidase. Archives of Biochemistry and Biophysics, 249, 8-14.